Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Diarrhea × Loperamide × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2 Short Bowel Syndrome 1 Esophageal Squamous Cell Carcinoma 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Octreotide 3 maltodextrin 1 lanreotide 1 Sulfasalazine 1 Radiation 1 Loperamide 1 Levofloxacin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003057 2023-06-18

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡